QCM
CAI

Quantinno Capital Management’s Caris Life Sciences CAI Stock Holding History

Quantinno Capital Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.87M Buy
441,672
+300,763
+213% +$5.38M 0.01% 1080
2026
Q1 		$2.52M Buy
140,909
+75,987
+117% +$1.66M ﹤0.01% 1481
2025
Q4 		$1.75M Sell
64,922
-7,301
-10% -$206K ﹤0.01% 1425
2025
Q3 		$2.18M Buy
+72,223
New +$2.3M 0.01% 1194

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quantinno Capital Management's CAI Position: Q2 2026 in Review

Quantinno Capital Management increased its Caris Life Sciences (CAI) stake by 213% in Q2 2026, buying an estimated $5.38M and bringing the position to 441,672 shares worth $7.87M. The position accounts for 0.01% of the portfolio, ranked #1080.

Quantinno Capital Management first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Quantinno Capital Management held 441,672 shares of Caris Life Sciences worth $7.87M as of Q2 2026.
  • Quantinno Capital Management bought 300,763 Caris Life Sciences shares in Q2 2026, an estimated $5.38M.
  • Caris Life Sciences made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1080 holding.
  • Quantinno Capital Management first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.